SCHEMBL10594583

SCHEMBL10594583

Cc1cc(OCC(O)CNC(C)(C)CNC(=O)CCCCO[N+](=O)[O-])c2cc(C#N)c(=O)[nH]c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 12/20 0.37
▸ CASR P41180 7/20 0.37
▸ ADRB2 P07550 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ SLC6A2 P23975 4/20 0.35
▸ SLC6A4 P31645 4/20 0.35
▸ SLC6A3 Q01959 4/20 0.35
▸ KCNH2 Q12809 4/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ SLC22A1 O15245 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10591715 0.98 CYP2D6 (0.38) CYP2D6CASRADRB2CYP1A2CYP3A4
SCHEMBL10594731 0.90 CYP2D6 (0.48) CYP2D6CASRADRB2CYP1A2CYP3A4
SCHEMBL10595607 0.90 ADRB1 (0.38) ADRB2CYP1A2MEN1KMT2A
SCHEMBL10592256 0.88 CYP2D6 (0.49) CYP2D6CASRADRB2CYP1A2CYP3A4
SCHEMBL10503386 0.88 ADRB1 (0.39) ADRB2CYP1A2MEN1KMT2A
SCHEMBL10593255 0.86 L3MBTL1 (0.40) CYP2D6CASRADRB2CYP1A2L3MBTL1
SCHEMBL10593609 0.84 L3MBTL1 (0.40) CYP2D6CASRADRB2CYP1A2CYP3A4
SCHEMBL10504578 0.81 L3MBTL1 (0.41) CYP2D6ADRB2CYP1A2CYP3A4L3MBTL1
SCHEMBL10506715 0.81 CYP2D6 (0.61) CYP2D6CASRADRB2CYP1A2CYP3A4
SCHEMBL10504063 0.80 HTR1A (0.55) CYP2D6CASRADRB2CYP1A2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback